Browsing by Subject "Kidney Disease"
Now showing items 1-11 of 11
-
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3.
(2012-04)BACKGROUND: Body Mass Index (BMI) as a marker of obesity is an established risk factor for chronic kidney disease (CKD) and cardiovascular disease (CVD). However, BMI can overestimate obesity. Anthropomorphic measurements ... -
Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function.
(2011-10)s.korsheed@googlemail.com BACKGROUND: Native arteriovenous fistula (AVF) is the vascular access of choice and its use cf. catheters is associated with sustained reduction in mortality. This may be due to factors beyond ... -
Establishing a Core Outcome Measure for Fatigue in Patients on Hemodialysis: A Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop Report.
(2018-03)Fatigue is one of the most highly prioritized outcomes for patients and clinicians, but remains infrequently and inconsistently reported across trials in hemodialysis. We convened an international Standardized Outcomes in ... -
Longitudinal Trends in Quality of Life and Physical Function in Frail Older Dialysis Patients: A Comparison of Assisted Peritoneal Dialysis and In-center Hemodialysis
(2019-01)BACKGROUND: In-center hemodialysis (HD) has been the standard treatment for older dialysis patients, but reports suggest an associated decline in physical and cognitive function. Cross-sectional data suggest that assisted ... -
Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment.
(2016-08)PURPOSE OF REVIEW: With ageing populations, the prevalence of multimorbidity is increasing. This review discusses recent developments in the understanding of multimorbidity in the context of chronic kidney disease (CKD). ... -
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.
(2011-10)BACKGROUND AND OBJECTIVES: Tissue advanced glycation end products (AGE) accumulation is a measure of cumulative metabolic stress. Assessment of tissue AGE by skin autofluorescence (SAF) correlates well with cardiovascular ... -
Skin autofluorescence: an emerging biomarker in persons with kidney disease.
(2019-11)PURPOSE OF REVIEW: Skin autofluorescence (SAF) is a measure of the accumulation of advanced glycation end-products (AGEs) proposed to act as a marker of 'cumulative metabolic stress'. This article discusses mechanisms of ... -
The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.
(2011-11)BACKGROUND AND OBJECTIVES: Endotoxin (ET) is recognized to cause adverse effects on cardiovascular (CV) structure. Circulatory translocation of gut bacterial ET is described in heart failure. Chronic kidney disease (CKD) ...
